Short answer · Medically reviewed summary · Last updated: 2023-07-13
Trichorhinophalangeal Syndrome (TRPS) is a rare genetic disorder characterized by distinctive facial features, skeletal abnormalities, and hair abnormalities. It is divided into three subtypes: TRPS type I, TRPS type II, and TRPS type III.
What is the prevalence of Trichorhinophalangeal Syndrome?
Prevalence of Trichorhinophalangeal Syndrome: how many people are affected worldwide, differences by sex and region, with sources.
Trichorhinophalangeal Syndrome (TRPS) is a rare genetic disorder characterized by distinctive facial features, skeletal abnormalities, and hair abnormalities. It is divided into three subtypes: TRPS type I, TRPS type II, and TRPS type III.
The prevalence of TRPS is extremely low, making it a rare condition. However, the exact prevalence is not well-established due to its rarity and underdiagnosis. It is estimated that TRPS type I is the most common subtype, followed by TRPS type II and TRPS type III.
TRPS affects both males and females, and its symptoms can vary widely among individuals. Common features include short stature, cone-shaped epiphyses (abnormal bone development), sparse scalp hair, thin nails, and distinctive facial characteristics such as a bulbous nose and a long philtrum.
As a rare genetic disorder, TRPS requires a multidisciplinary approach for diagnosis and management. Genetic testing and clinical evaluation are crucial for accurate diagnosis. Although there is no cure for TRPS, treatment focuses on managing the symptoms and improving the quality of life for affected individuals.
